ES476913A1 - Tetradeca peptides - Google Patents

Tetradeca peptides

Info

Publication number
ES476913A1
ES476913A1 ES476913A ES476913A ES476913A1 ES 476913 A1 ES476913 A1 ES 476913A1 ES 476913 A ES476913 A ES 476913A ES 476913 A ES476913 A ES 476913A ES 476913 A1 ES476913 A1 ES 476913A1
Authority
ES
Spain
Prior art keywords
compounds
novel
tetradeca
peptides
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES476913A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US04/874,173 external-priority patent/US4151394A/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES476913A1 publication Critical patent/ES476913A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Novel, therapeutically active compounds have the following formula < IMAGE > in which Y denotes D-Val or D-Ala. The compounds can also be in the form of pharmaceutically acceptable acid addition salts. The compounds of the formula I are prepared by oxidising a corresponding tetradecapeptide, the two sulphydryl groups being converted into a disulphide bridge. The novel compounds can be used for inhibiting the release of growth hormones and for reducing intestinal motility.
ES476913A 1977-04-21 1979-01-16 Tetradeca peptides Expired ES476913A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78947377A 1977-04-21 1977-04-21
US04/874,173 US4151394A (en) 1978-02-01 1978-02-01 Guidance system for arc welder

Publications (1)

Publication Number Publication Date
ES476913A1 true ES476913A1 (en) 1979-09-16

Family

ID=27120917

Family Applications (2)

Application Number Title Priority Date Filing Date
ES469004A Expired ES469004A1 (en) 1977-04-21 1978-04-20 Tetradeca peptides
ES476913A Expired ES476913A1 (en) 1977-04-21 1979-01-16 Tetradeca peptides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES469004A Expired ES469004A1 (en) 1977-04-21 1978-04-20 Tetradeca peptides

Country Status (23)

Country Link
JP (1) JPS53132589A (en)
AR (1) AR229798A1 (en)
AT (1) AT360675B (en)
AU (1) AU518731B2 (en)
BG (2) BG28705A4 (en)
CA (1) CA1120030A (en)
CH (1) CH634040A5 (en)
DD (1) DD136739A5 (en)
DE (1) DE2816855A1 (en)
DK (1) DK174178A (en)
EG (1) EG14800A (en)
ES (2) ES469004A1 (en)
FI (1) FI64575C (en)
FR (1) FR2387942A1 (en)
GB (1) GB1596329A (en)
GR (1) GR69789B (en)
IE (1) IE46617B1 (en)
IL (1) IL54532A (en)
IT (1) IT1094471B (en)
NL (1) NL7804219A (en)
NZ (1) NZ187010A (en)
PT (1) PT67912B (en)
SE (1) SE7804398L (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8423431D0 (en) * 1984-09-17 1984-10-24 Sandoz Ltd Organic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2608336A1 (en) * 1975-03-11 1976-09-30 Sandoz Ag NEW ORGANIC COMPOUNDS, THEIR PRODUCTION AND USE
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides

Also Published As

Publication number Publication date
ES469004A1 (en) 1979-09-01
DK174178A (en) 1978-10-22
JPS53132589A (en) 1978-11-18
CA1120030A (en) 1982-03-16
GR69789B (en) 1982-07-07
FI781183A (en) 1978-10-22
GB1596329A (en) 1981-08-26
SE7804398L (en) 1978-10-22
EG14800A (en) 1985-06-30
FI64575B (en) 1983-08-31
IL54532A0 (en) 1978-07-31
DE2816855A1 (en) 1978-11-02
AR229798A1 (en) 1983-11-30
BG28704A3 (en) 1980-06-16
NZ187010A (en) 1980-08-26
PT67912B (en) 1979-11-14
ATA282978A (en) 1980-06-15
NL7804219A (en) 1978-10-24
IL54532A (en) 1983-03-31
AU518731B2 (en) 1981-10-15
AU3534178A (en) 1979-10-25
IT1094471B (en) 1985-08-02
AT360675B (en) 1981-01-26
FI64575C (en) 1983-12-12
BG28705A4 (en) 1980-06-16
IT7822553A0 (en) 1978-04-20
FR2387942A1 (en) 1978-11-17
IE780766L (en) 1978-10-21
PT67912A (en) 1978-05-01
CH634040A5 (en) 1983-01-14
DD136739A5 (en) 1979-07-25
FR2387942B1 (en) 1981-06-26
IE46617B1 (en) 1983-08-10

Similar Documents

Publication Publication Date Title
ES473451A1 (en) Imidazole derivatives their synthesis and their pharmaceutical formulations.
ES8102125A1 (en) intermediates and their preparation.
HUT38950A (en) Process for producing 2-substituted-1,3-propylidene-diphosphonate derivatives and pharmaceutical compositions containing them as active agents
ES478156A1 (en) Heterocyclic compound
ES472847A1 (en) 2-Bromo-ergosine and its acid addition salts, method for its preparation and its application as a medicine.
ES468218A1 (en) Thioxanthones
ES469671A1 (en) Sulfur-containing benzimidazole derivatives
ZA816259B (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
NO800724L (en) PROCEDURE FOR PREPARING PEPTIDES WITH UBIQUIT-SIMILAR ACTIVITY
ES466851A1 (en) 2-Bromo-6-fluoro-N-(2-imidazolidinylidene)-benzamine and salts thereof and the use to treat hypertension
ES8103071A1 (en) Amino derivatives of benzothiazole, process for their preparation and their use in therapy.
ES449939A1 (en) O {8 (O-piperazinocarbonyl-phenyl)-thio{9 -benzoates
DE3362908D1 (en) Process for preparing trithiocarbonic acid diesters
ES477785A1 (en) 2-Phenylimino-imidazolidines and salts thereof
GR852867B (en)
ES455691A1 (en) N-Benzhydryl-3-methyl-3-(dialkoxy)benzyl-piperazines
ES480113A1 (en) Derivatives of 2-imino-imidazolidine, processes for their preparation, pharmaceutical compositions containing them and intermediates.
ES478874A1 (en) 3-0-( beta -D-Glucuronopyranosyl)-soyasapogenol B
ES476913A1 (en) Tetradeca peptides
ES462755A1 (en) Pesticidal 2-isopropyl-4-phenyl-3-butenoic acid benzyl esters
ES474367A1 (en) New benzo [d] thiazole derivatives, process for their preparation and their therapeutic applications
ES472708A1 (en) Bromhexine derivatives and process for making same
ES479033A1 (en) Substituted N- Iminomethylpiperidines
ES483532A1 (en) Alpha-aminophenylacetic acid derivatives for use in the treatment of inflammations and novel alpha-aminophenylacetic acid derivatives.
ES468133A1 (en) N-(2,3-dihydro-9-ergolen-8-ylmethyl) ureas